Enhancing access to innovative pharmaceutical products with HEOR
Today’s clinical development process includes additional steps that include communicating the value proposition, demonstrating clinical and economic evidence to a multitude of stakeholders: private payers, providers, entire health systems, HTA agencies, PBMs, etc.
Demonstrating the value of your innovations to these audiences is critical to define economic value and maxime patient access. Stage Analytics’ health economics and outcomes research (HEOR) is your thinking partner to work alongside you throughout this process.
Helping our clients achieve their goals
We empower our clients with the data and insights to establish your value narrative. Through our HEOR services, we support clients in the development, execution, and dissemination of the clinical and economic evidence to ensure effective patient access.
Our team of experienced health economists, epidemiologists, and data scientists have significant experience in applying advanced economic methods to effectively capture all dimensions of value of healthcare innovations. We work with our clients to ensure that the manufacturers effectively communicate value and maximize patient access.
Our services also include support to ICER reviews and engagement with health technology assessment agencies for US-based and international clients, to optimize performance and increase the likelihood of approval.
Get industry insights and Stage Analytics news in your inbox!